A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B.

Dillman, R O

A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B. [electronic resource] - Blood Nov 1991 - 2520-6 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0006-4971


Acute Disease
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cytarabine--administration & dosage
Daunorubicin--administration & dosage
Dose-Response Relationship, Drug
Female
Follow-Up Studies
Humans
Leukemia, Myeloid--drug therapy
Male
Middle Aged
Prednisone--administration & dosage
Remission Induction
Thioguanine--administration & dosage
Time Factors
Vincristine--administration & dosage